Abstract

Extemporaneous Formulations in Pediatric Patients

Author(s): Nahata Milap C

Issue: Jul/Aug 1999 - Compounding Parenteral Products

Page(s): 274-276

Download in electronic PDF format for $75
  • Extemporaneous Formulations in Pediatric Patients Page 1
  • Extemporaneous Formulations in Pediatric Patients Page 2
  • Extemporaneous Formulations in Pediatric Patients Page 3

Abstract

Extemporaneous drug formulations are important in treating pediatric patients, and pharmacists have a unique role in compounding these medicines for use in their patients. The author discusses the need for compounding, required studies for extemporaneous formulations (physicochemical properties, physical and chemical stability, palatability and miscellaneous) and new regulations. A table provides a listing of examples of drugs not available in liquids. The author concludes that joint efforts by various groups are required for making extemporaneous formulations accessible to the most vulnerable populations.

Related Keywords

  • "off-label" use
  • chemical stability
  • children
  • infants
  • IV drugs
  • liquid-dosage form
  • palatability
  • pediatric patients
  • physical stability

Related Categories

  • PEDIATRICS
  • STABILITIES, COMPATIBILITIES
  • FDA

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 1999
Pg. 274-276
Extemporaneous Formulations in Pediatric Patients
Author(s): Nahata Milap C
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Mar/Apr 1997
Pg. 84-86
Compounding for the Pediatric Patient
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 9-12
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Author(s): Schotik Debora
Jul/Aug 2019
Pg. 324-331
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
May/Jun 2007
Pg. 220-225
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jul/Aug 2008
Pg. 372-374
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Author(s): Gupta Vishnu D
Jan/Feb 2009
Pg. 14-18
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
May/Jun 2007
Pg. 259-261
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Author(s): Gupta Vishnu D
Nov/Dec 2005
Pg. 456-461
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Author(s): Fonseca Simonne C
Jan/Feb 2011
Pg. 78-80
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form
Author(s): Gupta Vishnu D, Gupta Vikas S
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Sep/Oct 2009
Pg. 445-446
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms
Author(s): Gupta Vishnu D
Nov/Dec 2005
Pg. 484-486
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Author(s): Gupta Vishnu D
Mar/Apr 2005
Pg. 165-166
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form
Author(s): Gupta Vishnu D, Sood Arun
Jul/Aug 2022
Pg. 342-351
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Nov/Dec 2005
Pg. 437-442
Pediatric Oral Liquid Preparations
Author(s): Fonseca Simonne C, Ferreira Anderson de O
Sep/Oct 2003
Pg. 389-393
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Author(s): Alexander Kenneth S, Thyangarajapuram N
May/Jun 2018
Pg. 240-246
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Author(s): Khokhlova Kateryna O, Zdoryk Oleksandr A
Jan/Feb 2016
Pg. 6-10
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Author(s): Choo Winnie